Genprex Inc (GNPX)

08:55 AM

Genprex (GNPX) Receives European Patent Intent for Cancer Gene T - GuruFocus

08:55 AM

07:51 AM

Genprex gets EU nod to grant patent for Reqorsa and PD-1 antibody combo to treat cancer - MarketScreener

07:51 AM

07:35 AM

Genprex Secures European Patent for Reqorsa® Therapy - TipRanks

07:35 AM

07:34 AM

Genprex to receive European patent for cancer gene therapy combination - Investing.com

07:34 AM

07:15 AM

Genprex Announces European Patent Intent for Reqorsa® Gene Therapy - TradingView

07:15 AM

07:03 AM

Is Genprex Inc. stock safe for conservative investors2025 Bull vs Bear & Verified Entry Point Detection - newser.com

07:03 AM

07:00 AM

Genprex (NASDAQ: GNPX) gets EPO intent to grant patent for REQORSA+PD-1 in cancer - Stock Titan

07:00 AM

05:27 AM

Why Genprex Inc. stock remains a top recommendationEarnings Beat & AI Enhanced Trading Alerts - newser.com

05:27 AM

03:58 AM

Can Genprex Inc. (2DE0) stock stage a strong rebound this quarterMarket Sentiment Review & Long-Term Safe Return Strategies - newser.com

03:58 AM

01:55 AM

Analyzing drawdowns of Genprex Inc. with statistical toolsJuly 2025 Catalysts & Long-Term Capital Growth Strategies - newser.com

01:55 AM

Nov 03, 2025

Will Genprex Inc. stock deliver consistent dividendsPortfolio Gains Summary & Low Risk High Win Rate Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Why Genprex Inc. stock remains undervalued2025 Key Lessons & Weekly Breakout Stock Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Genprex Inc. stock retracement – recovery analysis2025 Top Gainers & Smart Allocation Stock Tips - newser.com

Nov 03, 2025

Nov 03, 2025

What technical models suggest about Genprex Inc.’s comebackJuly 2025 Review & High Conviction Investment Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

How Genprex Inc. stock responds to policy changes2025 Big Picture & Low Risk Entry Point Tips - newser.com

Nov 03, 2025

Nov 03, 2025

Why Genprex Inc. stock is popular among millennialsMarket Weekly Review & Long-Term Safe Investment Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Can Genprex Inc. (2DE0) stock reach $200 price targetEarnings Miss & Short-Term High Return Strategies - newser.com

Nov 03, 2025

Nov 03, 2025

How to integrate Genprex Inc. into portfolio analysis toolsPortfolio Update Report & Verified Chart Pattern Signals - newser.com

Nov 03, 2025

Nov 03, 2025

What indicators show strength in Genprex Inc.2025 Market Overview & Daily Risk Controlled Trade Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Can Genprex Inc. (2DE0) stock sustain margin levels2025 Analyst Calls & Growth Focused Entry Reports - newser.com

Nov 03, 2025

Nov 03, 2025

Why analysts recommend Genprex Inc. (2DE0) stock2025 Technical Patterns & Safe Capital Preservation Plans - newser.com

Nov 03, 2025

Nov 02, 2025

Tools to monitor Genprex Inc. recovery probability2025 Volatility Report & Safe Capital Preservation Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Backtesting results for Genprex Inc. trading strategiesWeekly Stock Analysis & Short-Term Trading Alerts - newser.com

Nov 02, 2025

Nov 01, 2025

Will Genprex Inc. stock reach Wall Street targetsEarnings Overview Summary & AI Enhanced Trade Execution Alerts - newser.com

Nov 01, 2025

Nov 01, 2025

Is Genprex Inc. stock ready for a breakout2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com

Nov 01, 2025

Oct 31, 2025

Can technical indicators confirm Genprex Inc.’s reversalQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com

Oct 31, 2025

Oct 31, 2025

How institutional ownership impacts Genprex Inc. stockJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

How Genprex Inc. (2DE0) stock reacts to Fed tightening2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com

Oct 31, 2025